NEWS
Latest news and updates from ECO MEDICS AG
ANALYZER CLD 88 for reliable PCD diagnosis
The European Respiratory Society (ERS) has recently published a new technical standard on the measurement of nasal nitric oxide to improve the diagnosis of Primary Ciliary Dyskinesia (PCD) in preschool age children. PCD is a rare genetic disorder that can lead to...
Prediction of Asthma Exacerbations by Alveolar NO
The question how to better predict future asthma exacerbations was recently studied by analysing alveloar NO parameters. In asthma diagnosis and monitoring, the fraction of exhaled nitric oxide (FeNO) at a flow of 50 ml/s is standardized and routinely measured. It is...
EU-MDR Approval
We proudly announce that ECO PHYSICS AG, the legal manufacturer of the ECO MEDICS medical devices, has been granted certification under the new MDR. The Medical Device Regulation (EU) 2017/745, also referred to as MDR, replaces the EU Medical Device Directive (MDD,...
GPP Congress 2022
ECO MEDICS presented the pulmonary function testing devices, ANALYZER CLD 88 and EXHALYZER®D at the GPP congress, which was held in Bern (Switzerland) from September 28-30. Many scientific contributions reported studies, which have been performed with the ANALYZER CLD...
ERS Congress 2022
We were excited to be back on site at the ERS congress in Barcelona. Thanks to everyone who visited our booth! The three congress days were filled with many good discussions and it was a pleasure to see that our devices, the ANALYZER CLD 88 Series and EXHALYZER®D were...
Positive Evaluation of SPIROWARE 3.3.1
The impact of SPIROWARE® 3.3.1 with improved sensor accuracy on N2-MBW data was was elaborated by Paul Robinson and colleagues from Australia, Canada and the UK. They re-analysed multiple breath washout data from 1036 test occasions derived from measurements with the...
Improving MBW Quality
The LCI Core Facility located at the Royal Brompton Hospital, London is committed to standardize performance, data collection and quality control of multiple breath washout (MBW) measurements for multicentre clinical trial use. The competence center was inititate...
Lung Function Testing during COVID-19 Pandemic
At the beginning of the COVID-19 pandemic, many lung function laboratories closed down or operated at half load only. The risk of transmitting SARS-CoV-2 from aerosols generated during the test was too high. As SARS-CoV-2 will continue to be around, new hygiene and...
Volumetric Capnography in Infants
Volumetric capnography can reveal interesting physiological information on pulmonary gas exchange. Volumetric capnography parameters are calculated for all EXHALYZER®D multiple breath measurements using SPIROWARE® 3.3.x. A recent study in the Journal of Pediatrics by...
New N2MBW Video
In this short video, we show how to perform a nitrogen multiple breath test. We use the EXHALYZER®D for the measurement and SPIROWARE® software for the evaluation and documenation of the results. Watch the video.
NO Analysis among Cross-Country Skiers
An interesting scientific article for winter season was recently published by Marieann Högman and colleagues from Sweden who performed an extended NO analysis in elite junior cross-country skiers before and after a maximum oxygen uptake (V̇O2-max) test using roller...
Looking back at the virtual ERS congress 2020
The virtual ERS congresss 2020 showed for another time numerous contributions regarding asthma or PCD research using FeNO analysis and COPD and cystic fibrosis research applying multiple breath washouts. Many of those research studies used one of the ECO MEDICS...
ECO MEDICS at the virtual ERS International Congress 2020
This year the ERS International Congress is for the very first time a virtual event. ECO MEDICS is present with a virtual booth exhibiting the EXHALYZER®D and ANALYZER CLD 88 sp devices and also the new SPIROWARE®3.3 Software. The virtual booth includes the...
Launch of SPIROWARE Version 3.3
We are ready! The new SPIROWARE® Software Version 3.3 will be launched on September 7 during the ERS virtual congress. The new SPIROWARE® comes with several new applications and new functions for a better user experience. Here is a preview of the new applications:...
Routine MBW testing on CF infants in Denmark
Denmark has recently introduced routine MBW testing on CF infants every three months and report on their experience from the first year in an article by Schmidt and colleagues from the CF centre at Copenhagen. Tests are performed using the wash-in/wash-out technique...
Reference values for N2MBW testing
The so far largest reference data set for nitrogen multiple breath washout (N2MBW) testing has been obtained from an international multi-center study at four pediatric centers in Australia, Canada, Germany and Switzerland. MBW tests were performed on healthy Caucasian...
ERS Recommendations for Lung Function Testing during COVID-19 Pandemic
Lung function tests bear the risk of generating aerosols and it is known that Corona virus can be transmitted via aerosols. How can lung function tests be performed with a minimal risk of infection for patients and staff? The European Respiratory Society (ERS) has...
Information regarding COVID-19
According to the latest updates of the WHO and its recommendations for international traffic related to the COVID-19 outbreak, we regret to inform you, that ECO MEDICS AG and its affiliate offices are stopping international travel for its staff. This includes on-site...
Merry Christmas and a Happy New Year!
With the end of the year approaching, we would like to take the opportunity to thank all our customers, partners and collaborators for the trust placing in our company and products. We would like to wish you a very merry Christmas with your family and friends and a...
MBW Test on 11 months old Cystic Fibrosis Infant
The EXHALYZER® D was successfully used for multiple breath washout (MBW) tests on an 11 months old infant. This was reported in a case report presented at the 22. German Mucoviscidosis congress in Würzburg, Germany by T. Fuchs and H. Ellemunter from Innsbruck,...
ECO PHYSICS at German CF Congress
Our German subsidiary, ECO PHYSICS GmbH presented the EXHALYZER® D and ANALYZER CLD 88 sp at the 22nd German Mucoviscidosis Congress in Würzburg, Germany. Main topics discussed were the access and structures of palliative care, cystic fibrosis (CF) in the digital...
LCI outperforms spirometry in CF children
A scientific article using the EXHALYZER®D was recently published in the Journal of Cystic Fibrosis by K. M. Hardaker and colleagues from Sydney, Australia. The goal of the study was to determine the clinical and prognostic value of nitrogen multiple breath washout...
Medical Graphics Italia as new ECO MEDICS Partner
We are delighted to announce the new partnership with Medical Graphics Italia. Pietro Longo, CEO and company founder of Medical Graphics Italia S.r.l. and Dirk Wendt, CEO of ECO MEDICS AG have signed the distributorship agreement in Italy on September 17th. We are...
ECO MEDICS at ERS Congress in Madrid
The ERS International Congress, held in Madrid this year, is one of the most important meetings for pulmonologists and attracted more than 20’000 attendees from 130 countries all over the world. ECO MEDICS presented the ANALZER CLD 88 sp for FeNO measurements and the...
ECO MEDICS celebrates its 20th Anniversary
We are delighted to announce the 20th anniversary of ECO MEDICS AG.In September 1999, ECO MEDICS AG was founded in Dürnten, Switzerland. In the same year, the first generation of the ANALYZER CLD was already presented at the international ERS congress in...
ECO MEDICS Global Sales, Support and Service Network:
ECO MEDICS has a strong global network with local sales, support and service representatives. Please select your region and get in contact with us.
Sophisticated solutions for our customers
We acquire the most suitable partners – internally and externally – to develop and manufacture our products according to highest standards and to offer our customers superior service.
ECO MEDICS applies a process oriented management system, which is subject to continuous improvement. Products are CE MDD approved in accordance to ISO 13485 and the Council Directive 93/42/EEC for clinical use.